EU-28 pharmaceutical market

TRADELABOR has more than 20 years of experience in the control and treatment of air, working with an experienced and qualified technical staff and with the most advanced technology in this area, which together guarantee the quality of the services provided.

 

 

The detailed presentation of the European pharmaceutical markets shows a heterogeneous picture with regard to the market size and the development of the individual markets.

 

* Sales from observed markets plus estimates of unobserved submarkets result in the
total sales of a country at the selling price of pharmaceutical companies (ApU). No data
available for Malta and Cyprus.
** Pharmacy and hospital market data was available for these markets.
*** LCD: Local Currency Dollar – currency fluctuations in the country are not taken into
account, the growth in the countries is so comparable.
**** The figures in euros result from the translation of market data into underlying values
in US dollars (exchange rate: US dollars in euros = 1.263 : 1).
***** The total growth to LCD 2018 is a weighted value.
Own presentation BPI based on IQVIA™ – World Review Analyst 2019.

 

Continue at:  https://www.bpi.de/fileadmin/user_upload/Downloads/Publikationen/Pharma-Daten/Pharma-Daten_2019_EN.pdf

The text above is owned by the site above referred.

Here is only a small part of the article, for more please follow the link

Also see:

www.manostaxx.com

 

Manostaxx
Manostaxx – Industrial Management Consulting

Leave a Reply

Your email address will not be published. Required fields are marked *